Category: Uncategorized

Sep 15 2020

Uncategorized

Schizophrenia Tx Eases Depression in Bipolar Disorder

by Clinical Editor

No Comments

An atypical antipsychotic approved to treat schizophrenia improved depressive episodes for patients with bipolar disorder, according to an industry-supported trial. In a group of 333 patients with …

Sep 14 2020

Uncategorized

Add-On Nuplazid Gets a Win in Early Schizophrenia Trial

by Clinical Editor

No Comments

“Treatment of negative symptoms of schizophrenia remains a high unmet need as there are no currently approved treatments,” Bugarski-Kirola noted during her presentation. She explained that …

Sep 14 2020

Uncategorized

Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia

by Clinical Editor

No Comments

Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrate BI 425809 met its …

Sep 14 2020

Uncategorized

Schizophrenia Tx Eases Depression in Bipolar Disorder

by Clinical Editor

No Comments

An atypical antipsychotic approved to treat schizophrenia improved depressive episodes for patients with bipolar disorder, according to an industry-supported trial. In a group of 333 patients with …

Sep 14 2020

Uncategorized

Improved early psychosis detection system may halve risk in young people

by Clinical Editor

No Comments

Doctors have developed a new data mining method to detect many young people with emerging psychosis. The new methods, based on advanced data mining to pick up early risk sign...

Sep 14 2020

Uncategorized

Schizophrenia: Nurture cannot overcome nature

by Clinical Editor

No Comments

In the great nature vs. nurture debate, nature just got a win. UCI research led by Amal Alachkar found that too much of a certain amino acid in utero caused...

Sep 13 2020

Uncategorized

Schizophrenia Tx Eases Depression in Bipolar Disorder – MedPage Today

by Clinical Editor

No Comments

Schizophrenia Tx Eases Depression in Bipolar Disorder  MedPage Today

Sep 13 2020

Uncategorized

Schizophrenia Practice Guidelines Mostly Recommend Long-Acting Injectable Antipsychotics During First Episode – Psychiatry Advisor

by Clinical Editor

No Comments

Schizophrenia Practice Guidelines Mostly Recommend Long-Acting Injectable Antipsychotics During First Episode  Psychiatry Advisor

Sep 13 2020

Uncategorized

Add-On Nuplazid Gets a Win in Early Schizophrenia Trial

by Clinical Editor

No Comments

“Treatment of negative symptoms of schizophrenia remains a high unmet need as there are no currently approved treatments,” Bugarski-Kirola noted during her presentation. She explained that …

Sep 13 2020

Uncategorized

Schizophrenia Tx Eases Depression in Bipolar Disorder

by Clinical Editor

No Comments

An atypical antipsychotic approved to treat schizophrenia improved depressive episodes for patients with bipolar disorder, according to an industry-supported trial. In a group of 333 patients with …